Thursday, November 21, 2024

TOPIC

covaxin

News Reports

BHU professor’s controversial paper on Covaxin adverse effects retracted by journal, Bharat Biotech slaps Rs 5 crore defamation on all authors

OpIndia Staff -
On 24th September, the journal Drug Safety retracted a paper it had published in May 2024 regarding the safety of Covaxin made by Bharat Biotech
News Reports

How Covaxin continues to be targeted by vested interest groups: ICMR rejects BHU ‘study’ that claimed adverse effects, doctors highlight misleading methods

Anurag -
ICMR, in its statement on BHU's study about Covaxin side effects pointed out that there were several methodological flaws in the study.
News Reports

As Covid cases surge in China amid the failure of its vaccines, here is how ‘liberals’ had hailed China to run down India’s vaccination...

OpIndia Staff -
Indian liberals showed Indian vaccination program in bad light and hailed China
News Reports

‘Misleading and fallacious’: Govt refutes reports claiming that Covaxin approval was rushed due to political pressure, Bharat Biotech also denies

OpIndia Staff -
Govt of India and Bharat Biotech deny claims that approval for Covaxin was rushed and procedures were skipped
News Reports

Germany recognises Bharat Biotech’s Covid-19 vaccine Covaxin, removes testing requirements for travel from next month

OpIndia Staff -
German government had decided to recognise WHO-listed Covaxin for travels to Germany starting June 1.
News Reports

As Covid-19 vaccine precaution doses become available at private hospitals, Covishield and Covaxin prices cut to Rs 225

OpIndia Staff -
Serum Institute of India and Bharat Biotech reduce the price of Covishield and Covaxin vaccines to ₹225 per dose
News Reports

Court orders The Wire to take down 14 articles against Bharat Biotech and Covaxin, not to publish any more defamatory reports

OpIndia Staff -
A court in Telangana has ordered The Wire to take down 14 articles it had published against Bharat Biotech
News Reports

Studies suggest COVAXIN booster dose highly effective against Omicron and Delta variant: Details

OpIndia Staff -
Booster dose of COVAXIN is safe and may be necessary to ensure persistent immunity to prevent breakthrough infections.
News Reports

Pfizer CEO Bourla says COVID vaccines offer limited protection ‘if any’, adds third dose gives less protection against infection

OpIndia Staff -
Speaking exclusively to CNBC, Pfizer CEO Bourla stated that the vaccine against Omicron will be available in March.
News Reports

India’s COVID-19 vaccine coverage surpasses the 150-crore mark; 25% of the eligible teens register in the first week: Details

Gopal Tiwari -
The landmark feat of jabbing 150 crore doses was achieved on January 7, a year after the commencement of vaccination drive
123...8Page 1 of 8

Latest News

Recently Popular

Contact: [email protected]

About us

News and opinion website that brings you reports and narrative from a perspective often ignored or suppressed by the mainstream media of India.

Follow us

© OpIndia.com